New basis of the neurotrophic action of vitamin B12
- PMID: 14656022
- DOI: 10.1515/CCLM.2003.220
New basis of the neurotrophic action of vitamin B12
Abstract
Over the last few years we have reproduced all of the key morphological and biochemical features of human subacute combined degeneration in the central nervous system and peripheral nervous system of rats made cobalamin-deficient by means of total gastrectomy or a chronic cobalamin-deficient diet. We have also recently clarified the pathogenesis of experimental subacute combined degeneration induced in the rat by cobalamin deprivation. The results of our studies strongly support the notion that cobalamin plays a pivotal role in regulating the balance of the network of cytokines and growth factors in the central nervous system of the rat. We have demonstrated that cobalamin tightly regulates the central nervous system synthesis and/or the cerebrospinal fluid level of two cytokines, tumor necrosis factor-alpha and interleukin-6, and a growth factor, epidermal growth factor. Of these neuroactive agents, one, tumor necrosis factor-alpha, is neurotoxic, whereas the others are neurotrophic. Therefore, it becomes clear that cobalamin-deficient central neuropathy is caused not by the withdrawal of the vitamin, but reflects a locally increased production of neurotoxic agents, combined with the locally decreased production of neurotrophic agents.
Similar articles
-
Cobalamin (vitamin B(12)) in subacute combined degeneration and beyond: traditional interpretations and novel theories.Exp Neurol. 2005 Apr;192(2):463-79. doi: 10.1016/j.expneurol.2004.12.020. Exp Neurol. 2005. PMID: 15755562 Review.
-
New insights into the pathophysiology of cobalamin deficiency.Trends Mol Med. 2006 Jun;12(6):247-54. doi: 10.1016/j.molmed.2006.04.008. Epub 2006 May 11. Trends Mol Med. 2006. PMID: 16690356
-
Increased spinal cord NGF levels in rats with cobalamin (vitamin B12) deficiency.Neurosci Lett. 2006 Mar 27;396(2):153-8. doi: 10.1016/j.neulet.2005.11.029. Epub 2005 Dec 13. Neurosci Lett. 2006. PMID: 16352395
-
Experimental and clinical evidence of the role of cytokines and growth factors in the pathogenesis of acquired cobalamin-deficient leukoneuropathy.Brain Res Rev. 2008 Nov;59(1):42-54. doi: 10.1016/j.brainresrev.2008.05.001. Epub 2008 May 9. Brain Res Rev. 2008. PMID: 18538413 Review.
-
Clinically and MRI documented funicular myelosis in a patient with metabolical vitamin B12 deficiency but normal vitamin B12 serum level.J Neurol. 2003 Aug;250(8):1010-1. doi: 10.1007/s00415-003-1161-6. J Neurol. 2003. PMID: 12928928 No abstract available.
Cited by
-
Modulation of vigabatrin induced cerebellar injury: the role of caspase-3 and RIPK1/RIPK3-regulated cell death pathways.J Mol Histol. 2021 Aug;52(4):781-798. doi: 10.1007/s10735-021-09984-y. Epub 2021 May 27. J Mol Histol. 2021. PMID: 34046766
-
The Many Faces of Cobalamin (Vitamin B12) Deficiency.Mayo Clin Proc Innov Qual Outcomes. 2019 May 27;3(2):200-214. doi: 10.1016/j.mayocpiqo.2019.03.002. eCollection 2019 Jun. Mayo Clin Proc Innov Qual Outcomes. 2019. PMID: 31193945 Free PMC article. Review.
-
Just a vitamin? Should cobalamin (Vitamin B12) levels be checked in children with neurological disadvantages?North Clin Istanb. 2023 Nov 20;10(6):790-796. doi: 10.14744/nci.2022.33279. eCollection 2023. North Clin Istanb. 2023. PMID: 38328734 Free PMC article.
-
Homocysteine as a Predictor Tool in Multiple Sclerosis.Discoveries (Craiova). 2021 Sep 28;9(3):e135. doi: 10.15190/d.2021.14. eCollection 2021 Jul-Sep. Discoveries (Craiova). 2021. PMID: 34816003 Free PMC article.
-
[Pancytopenia and callosal nodules].Zhonghua Xue Ye Xue Za Zhi. 2018 Feb 14;39(2):165-167. doi: 10.3760/cma.j.issn.0253-2727.2018.02.019. Zhonghua Xue Ye Xue Za Zhi. 2018. PMID: 29562456 Free PMC article. Chinese. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical